12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Tuesday. Sharps Technology, Insmed, and Calliditas Therapeutics saw substantial gains, while Applied DNA Sciences, Innovative Eyewear, and Summit Therapeutics experienced notable declines.

May 28, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Calliditas Therapeutics shares moved upwards by 69.26% to $37.95, with a market cap of $1.0 billion. The company's Q1 earnings were released 3 days ago.
The price increase is likely driven by positive Q1 earnings results.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Insmed stock moved upwards by 112.72% to $46.8, with a market cap of $6.9 billion.
The substantial price increase suggests strong positive developments or investor sentiment.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Sharps Technology stock rose 140.0% to $0.51, with a market cap of $8.0 million.
The significant price increase indicates strong positive sentiment or news impacting the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Applied DNA Sciences stock decreased by 68.9% to $0.62.
The significant price drop indicates negative news or sentiment impacting the stock.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Innovative Eyewear shares fell 39.58% to $0.59, with a market cap of $10.3 million.
The substantial price decline suggests negative developments or investor sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Summit Therapeutics shares declined by 28.85% to $2.4, with a market cap of $1.6 billion.
The notable price decline indicates negative news or sentiment impacting the stock.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100